Safety and Efficacy of Topical Infliximab in Autoimmune Dry Eye Disease

Clinical trial NCT07671222 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07671222
Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sjogren Syndrome Sjogren Syndrome With Keratoconjunctivitis Dry Eye Disease (DED)

Start date: 2026-12-01
Primary completion: 2028-03-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.